Company Valuation: Edwards Lifesciences Corporation

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 80,883 46,128 46,246 43,663 49,471 52,271 - -
Change - -42.97% 0.25% -5.58% 13.3% 5.66% - -
Enterprise Value (EV) 1 80,616 45,956 45,198 40,285 45,843 48,789 47,199 45,356
Change - -42.99% -1.65% -10.87% 13.8% 6.43% -3.26% -3.9%
P/E 54.4x 30.6x 33.2x 10.6x 46.6x 32.4x 27.7x 24.7x
PBR 13.9x 7.82x 6.99x 4.36x 4.79x 4.78x 4.34x 4.15x
PEG - 12.14x -5.79x 0x -0.6x 0.6x 1.7x 2x
Capitalization / Revenue 15.5x 8.57x 7.7x 8.03x 8.15x 7.75x 7.05x 6.42x
EV / Revenue 15.4x 8.54x 7.53x 7.41x 7.56x 7.23x 6.37x 5.57x
EV / EBITDA 46.6x 23.7x 24.1x 24.1x 25.5x 23x 19.9x 16.9x
EV / EBIT 50.6x 25.6x 26.1x 26.6x 27.9x 24.9x 21.5x 18.4x
EV / FCF 57.3x 47.2x 47.9x 139x 34.3x 35.8x 27.9x 23.5x
FCF Yield 1.74% 2.12% 2.09% 0.72% 2.91% 2.79% 3.59% 4.26%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 2.38 2.44 2.3 6.97 1.83 2.804 3.273 3.671
Distribution rate - - - - - - - -
Net sales 1 5,232 5,382 6,005 5,440 6,068 6,748 7,411 8,146
EBITDA 1 1,729 1,936 1,879 1,670 1,800 2,122 2,372 2,682
EBIT 1 1,594 1,796 1,734 1,514 1,644 1,959 2,195 2,466
Net income 1 1,503 1,522 1,402 4,175 1,074 1,624 1,891 2,115
Net Debt 1 -267 -172.7 -1,048 -3,378 -3,628 -3,482 -5,073 -6,915
Reference price 2 129.55 74.61 76.25 74.03 85.25 90.78 90.78 90.78
Nbr of stocks (in thousands) 624,334 618,260 606,500 589,800 580,300 575,800 - -
Announcement Date 1/26/22 1/31/23 2/6/24 2/11/25 2/10/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
32.37x7.23x22.99x-.--% 52.27B
25.69x4.64x17.87x0.36% 191B
44.44x11.64x26.04x-.--% 143B
31.26x - - 0.73% 139B
16.25x3.38x10.89x-.--% 65.74B
18.03x2.09x10.7x2.92% 43.55B
26.42x5.27x18.2x0.75% 38.41B
45.38x6.36x19.59x-.--% 36.76B
14.66x1.64x9.18x0.24% 29.91B
18.9x4.97x12.82x1.21% 28.93B
Average 27.34x 5.24x 16.48x 0.62% 76.84B
Weighted average by Cap. 29.70x 6.15x 18.41x 0.48%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. EW Stock
  4. Valuation Edwards Lifesciences Corporation